Processa Pharmaceuticals, Inc. Revenue Breakdown
No Revenue Breakdown for PCSA on this site yet.
- 2022-12-31: Total revenue $0.00.
- 2021-12-31: Total revenue $0.00.
- 2016-12-31: Total revenue $5.00K.
- 2015-12-31: Total revenue $113.42K.
Source checked: the stored Revenue Breakdown page for PCSA.
Revenue by product
Each year (12 month)
| Fiscal year end | Total revenue |
|---|---|
| 2022-12-31 | $0.00 |
| 2021-12-31 | $0.00 |
| 2016-12-31 | $5.00K |
| 2015-12-31 | $113.42K |
| 2014-12-31 | $107.24K |
| 2013-12-31 | $312.48K |
| 2012-12-31 | $192.15K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2023-09-30 | Not split by product $0.00 | $0.00 |
| 2023-06-30 | Not split by product $0.00 | $0.00 |
| 2023-03-31 | Not split by product $0.00 | $0.00 |
| 2022-12-31 | Not split by product $0.00 | $0.00 |
| 2022-09-30 | Not split by product $0.00 | $0.00 |
| 2022-06-30 | Not split by product $0.00 | $0.00 |
| 2022-03-31 | Not split by product $0.00 | $0.00 |
| 2021-12-31 | Not split by product $0.00 | $0.00 |
| 2021-09-30 | Not split by product $0.00 | $0.00 |
| 2016-12-31 | Not split by product $0.00 | $0.00 |
| 2016-09-30 | Not split by product $0.00 | $0.00 |
| 2016-06-30 | Not split by product $0.00 | $0.00 |
| 2016-03-31 | Not split by product $5.00K 100.00% | $5.00K |
| 2015-12-31 | Not split by product $17.50K 100.00% | $17.50K |
| 2015-09-30 | Not split by product $58.16K 100.00% | $58.16K |
| 2015-06-30 | Not split by product $20.04K 100.00% | $20.04K |
| 2015-03-31 | Not split by product $37.76K 100.00% | $37.76K |
| 2014-12-31 | Not split by product -$78.56K 100.00% | -$78.56K |
| 2014-09-30 | Not split by product $52.62K 100.00% | $52.62K |
| 2014-06-30 | Not split by product $112.83K 100.00% | $112.83K |
| 2014-03-31 | Not split by product $20.43K 100.00% | $20.43K |
| 2013-12-31 | Not split by product $70.09K 100.00% | $70.09K |
| 2013-09-30 | Not split by product $125.91K 100.00% | $125.91K |
| 2013-06-30 | Not split by product $97.28K 100.00% | $97.28K |
| 2013-03-31 | Not split by product $19.20K 100.00% | $19.20K |
| 2012-12-31 | Not split by product $31.45K 100.00% | $31.45K |
| 2012-09-30 | Not split by product $49.06K 100.00% | $49.06K |
| 2012-06-30 | Not split by product $97.02K 100.00% | $97.02K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |